Fig. 7From: Adverse events in single-arm clinical trials with non-fatal time-to-event efficacy endpoint: from clinical questions to methods for statistical analysisSimulation results for scenario 3 of the IPCW estimator accounting for the presence of an interaction between \(X_1\) and \(X_2\) in the estimate of the weights. The grey horizontal line is the reference null biasBack to article page